Lysodren (mitotane) is a small molecule pharmaceutical. Mitotane was first approved as Lysodren on 1982-01-01. It is used to treat adrenocortical carcinoma and cushing syndrome in the USA. It has been approved in Europe to treat adrenal cortex neoplasms. It is known to target cholesterol side-chain cleavage enzyme, mitochondrial and cytochrome P450 11B1, mitochondrial.
|Indication||adrenal cortex neoplasms, adrenocortical carcinoma, cushing syndrome|